Gowling WLG advised NurExone on the private placement.NurExone Biologic Inc., a biopharmaceutical company pioneering the development of non-invasive ExoTherapy for treating traumatic spinal cord injuries, announced…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Georgio Naffaa
…
This content is for Standard 1 Year members only. LoginJoin Now